Curat Global, LLC Bio Rad Laboratories, Inc. Transaction History
Curat Global, LLC
- $82.1 Billion
- Q1 2025
A detailed history of Curat Global, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Curat Global, LLC holds 140 shares of BIO stock, worth $35,113. This represents 0.04% of its overall portfolio holdings.
Number of Shares
140Holding current value
$35,113% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding BIO
# of Institutions
449Shares Held
18.8MCall Options Held
12.7KPut Options Held
14.4K-
Vanguard Group Inc Valley Forge, PA1.91MShares$480 Million0.01% of portfolio
-
First Eagle Investment Management, LLC1.57MShares$393 Million0.8% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$389 Million0.01% of portfolio
-
Veritas Asset Management LLP913KShares$229 Million2.52% of portfolio
-
Dimensional Fund Advisors LP Austin, TX877KShares$220 Million0.05% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.18B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...